Autism and Nonsyndromic Mental Retardation Associated with a De Novo Mutation in the NLGN4X Gene Promoter Causing an Increased Expression Level


      Pathogenic mutations in the X-linked Neuroligin 4 gene (NLGN4X) in autism spectrum disorders (ASDs) and/or mental retardation (MR) are rare. However, nothing is known regarding a possible altered expression level of NLGN4X that would be caused by mutations in regulatory sequences. We investigated this issue by analyzing these regions in patients with ASDs and no mutation in the NLGN4X coding sequence.


      We studied 96 patients who met all DSM-IV criteria for autism. The entire coding sequence and the regulatory sequences of the NLGN4X gene were analyzed by polymerase chain reaction and direct sequencing.


      We identified a de novo 1 base pair (−335G>A) substitution located in the promoter region in a patient with autism and nonsyndromic profound MR. Interestingly, this variation is associated with an increased level of the NLGN4X transcript in the patient compared with male control subjects as well as his father. Further in vitro luciferase reporter and electrophoretic mobility shift assays confirmed, respectively, that this mutation increases gene expression and is probably caused by altered binding of transcription factors in the mutated promoter sequence.


      This result brings further insight about the phenotypic spectrum of NLGN4X mutations and suggests that the analysis of the expression level of NLGN4X might detect new cases.

      Key Words

      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'


      Subscribe to Biological Psychiatry
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect


        • Freitag C.M.
        The genetics of autistic disorders and its clinical relevance: A review of the literature.
        Eur J Hum Genet. 2007; 14: 714-720
        • Laumonnier F.
        • Cuthbert P.C.
        • Grant S.G.
        The role of neuronal complexes in X-linked brain diseases.
        Am J Hum Genet. 2007; 80: 205-220
        • Jamain S.
        • Quach H.
        • Betancur C.
        • Rastam M.
        • Colineaux C.
        • Gillberg I.C.
        • et al.
        Mutations of the X-linked genes encoding neuroligins NLGN3 and NLGN4 are associated with autism.
        Nat Genet. 2003; 34: 27-29
        • Laumonnier F.
        • Bonnet-Brilhault F.
        • Gomot M.
        • Blanc R.
        • David A.
        • Moizard M.P.
        • et al.
        X-linked mental retardation and autism are associated with a mutation in the NLGN4 gene, a member of the Neuroligin family.
        Am J Hum Genet. 2004; 74: 552-557
        • Vincent J.B.
        • Kolozsvari D.
        • Roberts W.S.
        • Bolton P.F.
        • Gurling H.M.
        • Scherer S.W.
        Mutation screening of X-chromosomal neuroligin genes: No mutations in 196 autism probands.
        Am J Med Genet B Neuropsychiatr Genet. 2004; 129B: 82-84
        • Gauthier J.
        • Bonnel A.
        • St.-Onge J.
        • Karemera L.
        • Laurent S.
        • Mottron L.
        • et al.
        NLGN3/NLGN4 gene mutations are not responsible for autism in the Quebec population.
        Am J Med Genet B Neuropsychiatr Genet. 2005; 132: 74-75
        • Ylisaukko-oja T.
        • Rehnstrom K.
        • Auranen M.
        • Vanhala R.
        • Alen R.
        • Kempas E.
        • et al.
        Analysis of four neuroligin genes as candidates for autism.
        Eur J Hum Genet. 2005; 13: 1285-1292
        • Blasi F.
        • Bacchelli E.
        • Pesaresi G.
        • Carone S.
        • Bailey A.J.
        • Maestrini E.
        • International Molecular Genetic Study of Autism Consortium (IMGSAC)
        Absence of coding mutations in the X-linked genes neuroligin 3 and neuroligin 4 in individuals with autism from the IMGSAC collection.
        Am J Med Genet B Neuropsychiatr Genet. 2006; 141: 220-221
        • Yan J.
        • Oliveira G.
        • Coutinho A.
        • Yang C.
        • Feng J.
        • Katz C.
        • et al.
        Analysis of the neuroligin 3 and 4 genes in autism and other neuropsychiatric patients.
        Mol Psychiatry. 2005; 10: 329-332
        • Lawson-Yuen A.
        • Saldivar J.S.
        • Sommer S.
        • Picker J.
        Familial deletion within NLGN4 associated with autism and Tourette syndrome.
        Eur J Hum Genet. 2008; 16: 614-618
        • Livak K.J.
        • Schmittgen T.D.
        Analysis of relative gene expression data using real-time quantitative PCR and the 2(-delta delta C(T)) method.
        Methods. 2001; 25: 402-408
        • Cartharius K.
        • Frech K.
        • Grote K.
        • Klocke B.
        • Haltmeier M.
        • Klingenhoff A.
        • et al.
        MatInspector and beyond: Promoter analysis based on transcription factor binding sites.
        Bioinformatics. 2005; 21: 2933-2942
        • Kel A.E.
        • Goessling E.
        • Reuter I.
        • Cheremushkin E.
        • Kel-Margoulis O.V.
        • Wingender E.
        MATCH™: A tool for searching transcription factor binding sites in DNA sequences.
        Nucleic Acids Res. 2003; 31: 3576-3579
        • Bardwell V.J.
        • Treisman R.
        The POZ domain: A conserved protein–protein interaction motif.
        Genes Dev. 1994; 8: 1664-1677
        • Froyen G.
        • Van Esch H.
        • Bauters M.
        • Hollanders K.
        • Frints S.G.
        • Vermeesch J.R.
        • et al.
        Detection of genomic copy number changes in patients with idiopathic mental retardation by high-resolution X-array-CGH: Important role for increased gene dosage of XLMR genes.
        Hum Mutat. 2007; 28: 1034-1042
        • Chubykin A.A.
        • Atasoy D.
        • Etherton M.R.
        • Brose N.
        • Kavalali E.T.
        • Gibson J.R.
        • Südhof T.C.
        Activity-dependent validation of excitatory versus inhibitory synapses by neuroligin-1 versus neuroligin-2.
        Neuron. 2007; 54: 919-931
        • Dean C.
        • Scholl F.G.
        • Choih J.
        • DeMaria S.
        • Berger J.
        • Isacoff E.
        • Scheiffele P.
        Neurexin mediates the assembly of presynaptic terminals.
        Nat Neurosci. 2003; 6: 708-716
        • Graf E.R.
        • Zhang X.
        • Jin S.X.
        • Linhoff M.W.
        • Craig A.M.
        Neurexins induce differentiation of GABA and glutamate postsynaptic specializations via NLs.
        Cell. 2004; 119: 1013-1026
        • Varoqueaux F.
        • Aramuni G.
        • Rawson R.L.
        • Mohrmann R.
        • Missler M.
        • Gottmann K.
        • et al.
        Neuroligins determine synapse maturation and function.
        Neuron. 2006; 51: 741-754
        • Chih B.
        • Engelman H.
        • Scheiffele P.
        Control of excitatory and inhibitory synapse formation by neuroligins.
        Science. 2005; 307: 1324-1328
        • Durand C.M.
        • Betancur C.
        • Boeckers T.M.
        • Bockmann J.
        • Chaste P.
        • Fauchereau F.
        • et al.
        Mutations in the gene encoding the synaptic scaffolding protein SHANK3 are associated with autism spectrum disorders.
        Nat Genet. 2007; 39: 25-27
        • Moessner R.
        • Marshall C.R.
        • Sutcliffe J.S.
        • Skaug J.
        • Pinto D.
        • Vincent J.
        • et al.
        Contribution of SHANK3 mutations to autism spectrum disorder.
        Am J Hum Genet. 2007; 81: 1289-1297